Pathogen: clinical or host-associated sample from ... - BioSample

Pathogen: clinical or host-associated sample from Klebsiella michiganensis

Organism: Klebsiella michiganensis
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Klebsiella/Raoultella group; Klebsiella

Attributes

BioProjects: PRJNA391510
Retrieve all samples from this project

PRJNA316321 FDA/CDC Antimicrobial Resistant Isolate Bank
Retrieve all samples from this project

Submission: Centers for Disease Control and Prevention, Joseph Lutgring; 2017-06-28

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Testing standard
amikacin	susceptible	==	2	mg/L	MIC	CLSI
ampicillin	resistant	>	32	mg/L	MIC	CLSI
ampicillin-sulbactam	susceptible	==	8/4	mg/L	MIC	CLSI
aztreonam	resistant	>	64	mg/L	MIC	CLSI
cefazolin	resistant	>	8	mg/L	MIC	CLSI
cefepime	susceptible-dose dependent	==	4	mg/L	MIC	CLSI
cefotaxime	resistant	==	16	mg/L	MIC	CLSI
cefoxitin	resistant	>	16	mg/L	MIC	CLSI
ceftazidime	resistant	==	128	mg/L	MIC	CLSI
ceftazidime-avibactam	susceptible	<=	0.5/4	mg/L	MIC	missing
ceftolozane-tazobactam	susceptible	==	0.25/4	mg/L	MIC	CLSI
ceftriaxone	resistant	==	32	mg/L	MIC	CLSI
ciprofloxacin	susceptible	<=	0.25	mg/L	MIC	CLSI
colistin	not defined	<=	0.25	mg/L	MIC	missing
doripenem	susceptible	<=	0.12	mg/L	MIC	CLSI
ertapenem	susceptible	<=	0.12	mg/L	MIC	CLSI
gentamicin	susceptible	==	2	mg/L	MIC	CLSI
imipenem	susceptible	<=	0.5	mg/L	MIC	CLSI
levofloxacin	susceptible	<=	0.12	mg/L	MIC	CLSI
meropenem	susceptible	<=	0.12	mg/L	MIC	CLSI
piperacillin-tazobactam	susceptible	<=	4/4	mg/L	MIC	CLSI
polymyxin B	not defined	==	0.5	mg/L	MIC	missing
tetracycline	susceptible	<=	2	mg/L	MIC	CLSI
tigecycline	susceptible	<=	0.5	mg/L	MIC	missing
tobramycin	susceptible	==	4	mg/L	MIC	CLSI
trimethoprim-sulfamethoxazole	resistant	>	8/152	mg/L	MIC	CLSI